956 patients were identified (median age 40.1 years, 59.9% male). Atrial fibrillation prevalence was 9.2% and 38.2% received a transplant during follow-up. 26 (2.7%) experienced a stroke during 4409 patient-years of follow-up (84.6% ischemic).
Introduction
End-stage renal disease (ESRD) is associated with increased cardiovascular morbidity and mortality [1] -an effect which is reduced but not obliterated by renal transplantation. In the last two decades, much attention has turned toward cerebrovascular disease and its complications in those with ESRD. A recent report has provided insight into the relevance of stroke affecting those with ESRD in the 21 st century. Compared to the general population stroke incidence was found to be 6-fold greater and -of concern -younger patients were more likely to be affected [2] .
It is recognised that effective preventive strategies are urgently needed.
Patients undergoing renal replacement therapy (RRT) experience a unique physiological environment where the conventional, general population-based, stroke risk factors are not consistently found to be associated with stroke [3] . For instance, although atrial fibrillation (AF) is a common finding in patients on hemodialysis the effect of AF on stroke risk remains unclear [4] and is further complicated by the absence of clear benefit from warfarin use [5, 6] . Furthermore, vitamin K antagonists (warfarin) are associated with significant side effects, beyond that of bleeding in patients on hemodialysis, including accelerated vascular calcification [7] . Fortunately, the risk of stroke in those on the transplant waiting list can be reduced by receiving a renal transplant with sustained transplant function [8] . However, the assumption that return of "normal" renal function will produce stroke risk factors similar to those of the general population and provide benefit from their preventive strategies is unproven.
The goal of our study was to; 1) describe the incidence of stroke in those with a functioning renal transplant; 2) examine risk factors associated with stroke with particular interest in the effect of AF and warfarin use; and 3) describe outcomes following stroke. Data were analysed using SPSS version 21 (IBM, Armonk, New York).
Methods

All
Ethical approval
The west of Scotland ethics committee officer waived the need for ethical committee review on the basis that this was analysis of routine clinical data. Caldicott Guardian approval was granted by the information governance manager of NHS Greater Glasgow and Clyde.
Results
A total of 956 patients with a renal transplant were included; 591(61.8%) had a functioning transplant at the time of study inception and 365(38.2%) received a transplant during the study period. The mean age at commencing RRT for ESRD 
Discussion
Renal transplantation is the gold standard treatment for patients with ESRD [10] .
Whilst it is recognised that reducing cardiovascular risk factors at all stages of CKD is important [11] , the benefit of targeted therapies requires clarification in ESRD. We have described the incidence, associations of and outcomes following stroke in those with a functioning renal transplant in the west of Scotland over a 6-year period.
Our large single centre study describes a high stroke incidence, presence of conventional cardiovascular risk factors and, most striking, fatality outcomes worse than that expected in the general population. Further to this, although AF was associated with time to ischemic stroke, the key prevention strategy -warfarin -was not associated with benefit in our cohort.
Incidence
The incidence of cerebrovascular disease increases with worsening renal function and peaks at ESRD [12] . Of concern, previous reports have suggested that the initiation of dialysis itself may cause stroke [3] . Renal transplantation improves patient outcomes by reducing risk of cardiovascular related death [13, 14] however, the effect of transplantation on stroke risk has only recently been described [8] . In this retrospective USRDS review the authors describe that renal transplantation predicts a 34% reduction in risk of subsequent cerebrovascular events compared to remaining on the transplant waiting list. They describe an incidence of 24.6 cerebrovascular events/1000 patient-years in those who receive a renal transplant compared to 45.6 events/1000 patient years in those remaining on the waiting list. In another USRDS review a more recent study [15] presented an event incidence of 7.4 ischemic strokes/1000 patient years. This apparent difference in rates can be explained by different selection criteria but more so by the definition of cerebrovascular events between the two studies. The report with the higher incidence included all of ischemic stroke, hemorrhagic stroke and TIA rather than strictly ischemic stroke. With focus on the UK population, we have recently reported the stroke incidence of those receiving maintenance hemodialysis for ESRD as 41.5/1000 patient years[6] -a result significantly higher than the observed rate in the transplant population. Our present study has described the incidence within a welldefined population, observing an incidence rate of 5.96 cerebrovascular events/1000 patient-years -greater than twice the underlying incidence of stroke in the general population for Scotland [16] . Although high, we note this is lower than the only other UK published study describing incidence at 12.4/1000 patient years [17] . Whereas we report incidence of stroke in all patients attending our unit, the other study retrospectively assessed only those who were selected for a steroid-sparing immunosuppressant regime. The two studies' populations are therefore affected by this bias; for example pre-existing ischemic heart disease and diabetes were greater in their population compared to ours (14.8% and 25.4% v 7% and 17.2% respectively).
Stroke risk factors
Previous retrospective studies have attempted to clarify the risk factors underpinning stroke [18, 19] in the ESRD population. Surprisingly, conventional risk factors such as hypertension, hyperlipidemia and AF are not consistently associated with stroke risk in those receiving dialysis. Conversely in the transplant population, described risk factors mimic those seen in the general population.
Older age, diabetes, hypertension and AF are consistent findings on multivariable analyses [15, 17, 20, 21] .
Assessing our cohort as a whole we discovered age, prior stroke, diabetes, higher systolic blood pressure and AF were associated with stroke on univariable regression. Multivariable analysis found diabetes, systolic BP, age and prior stroke were significantly associated with stroke. Excluding cases with prior stroke we found that higher hemoglobin and presence of diabetes were independently associated with stroke. Serum creatinine was not associated with stroke. Using Kaplan-Meir survival analyses, we demonstrated a significant association between presence of AF and stroke, although we could not demonstrate a significant influence of warfarin on stroke in those with AF (figures 1 and 2).
Outcomes
All-cause mortality was significantly higher following stroke. An adjusted multivariable Cox regression analysis demonstrated a significant association between stroke and time to death. Further, case fatality (death within first 7 days)
following stroke was high and early outcomes were worse in those with first ever stroke. Our findings reveal that fatality rates are higher than the background population and more in keeping with those reported in the dialysis population [22] .
Whilst it is inevitable that suffering a stroke will negatively impact survival, the similarity of reported outcomes to those who remain on dialysis is notable and suggest an effect of ESRD which is not reduced by transplantation.
Study limitations
We describe the incidence, associations and outcomes of stroke in a large single centre renal transplant unit encompassing 956 patients over 4409 years of patient follow-up. Despite our large sample size and completeness of follow-up we do recognize the following limitations. As a retrospective study we can only describe association and not causation. The small number of strokes in the group of those receiving a transplant following a period on dialysis limits our ability to detect associations on multivariable regression -specifically, we acknowledge that the relatively low number of stroke events may lead to type 2 errors in our analyses, which may explain the absence of effect from atrial fibrillation on multivariable analysis. We have not included data on immunosuppressive medication, although we acknowledge recent evidence suggesting steroid use independently increases the risk of CVA [17] . Finally, important data were not available which may offer an explanation for the lack of effect from warfarin. For example, we are unable to comment on cases where warfarin was discontinued and the lack of INR reporting limits comment about time in the therapeutic range.
Conclusion
The incidence of stroke in those with a functioning renal transplant is higher than the background population, but markedly lower than those on hemodialysis. Stroke in transplant recipients is associated with similar conventional risk factors observed in the general population, but it remains unclear if reversal of modifiable factors can reduce stroke risk. Of primary interest, although AF is associated with time to stroke, prior warfarin use did not confer protection in this study. Further, the outcomes following stroke are dismal -resembling those who remain on dialysis. Dedicated trials for stroke therapies are needed in the transplant population to determine the reversibility of the increased stroke risk and the effects on outcomes.
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